NEW: We've expanded Stock Detail, Screener, and Maps with new data

Stock Detail, Screener:
3, 5, 10-Year Performance
EV/EBITDA, EV/Sales
Dividend Growth (1, 3, 5 Years)
EPS & Sales Growth (3 Years)

Maps:
All from Screener plus:
ROA, ROE, ROIC
Quick & Current Ratios
LT Debt and Debt to Equity Ratios
Gross, Operating, and Net Margins

APLT

Applied Therapeutics Inc

Jul 03 • 04:00PM ET

0.3200

Dollar change -0.0183
Percentage change -5.41	%

Healthcare • Biotechnology • USA • NASD

Peers: GILD VRTX REGN BMRN ALNY IONS ACAD NBIX RARE KPTI

| Held by: SURI VTI VXF IBB VTWO SCHA IWM VHT TMED IWO

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-0.43	Insider Own	17.56%	Shs Outstand	141.58M	Perf Week	-15.79%
Market Cap	45.30M	Forward P/E	-	EPS next Y	-0.46	Insider Trans	-0.65%	Shs Float	116.71M	Perf Month	-10.11%
Enterprise Value	-2.76M	PEG	-	EPS next Q	-0.17	Inst Own	74.84%	Short Float	18.27%	Perf Quarter	-27.44%
Income	-43.51M	P/S	167.78	EPS this Y	19.41%	Inst Trans	-5.66%	Short Ratio	8.61	Perf Half Y	-60.74%
Sales	0.27M	P/B	1.24	EPS next Y	24.90%	ROA	-41.81%	Short Interest	21.33M	Perf YTD	-62.63%
Book/sh	0.26	P/C	0.89	EPS next 5Y	24.56%	ROE	-83.71%	52W High	10.62 -96.99%	Perf Year	-93.06%
Cash/sh	0.36	P/FCF	-	EPS past 3/5Y	43.17% 26.57%	ROIC	-111.73%	52W Low	0.29 8.47%	Perf 3Y	-64.07%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	-54.14%	Volatility	11.75% 9.38%	Perf 5Y	-99.09%
Dividend TTM	-	EV/Sales	-10.22	EPS Y/Y TTM	78.99%	Oper. Margin	-40875.94%	ATR (14)	0.04	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	3.00	Sales Y/Y TTM	-	Profit Margin	-16357.52%	RSI (14)	43.26	Recom	2.25
Dividend Gr. 3/5Y	- -	Current Ratio	3.00	EPS Q/Q	77.50%	SMA20	-8.69%	Beta	1.93	Target Price	3.17
Payout	-	Debt/Eq	0.07	Sales Q/Q	-100.00%	SMA50	-17.73%	Rel Volume	0.75	Prev Close	0.34
Employees	35	LT Debt/Eq	0.06	Earnings	May 13 AMC	SMA200	-88.23%	Avg Volume	2.48M	Price	0.32
IPO	May 14, 2019	Option/Short	Yes / Yes	EPS/Sales Surpr.	17.81% -100.00%	Trades		Volume	1,859,773	Change	-5.41%

Date	Action	Analyst	Rating Change	Price Target Change
Dec-23-24	Downgrade	William Blair	Outperform → Mkt Perform
Dec-02-24	Downgrade	UBS	Buy → Neutral	$13 → $2
Nov-29-24	Downgrade	RBC Capital Mkts	Outperform → Sector Perform	$12 → $4
Jul-31-24	Initiated	William Blair	Outperform
Mar-26-24	Initiated	RBC Capital Mkts	Outperform	$12
Feb-22-24	Initiated	Leerink Partners	Outperform	$12
Jan-04-22	Downgrade	Barclays	Overweight → Equal Weight	$44 → $7
Aug-27-21	Downgrade	Goldman	Neutral → Sell	$16 → $10
Jun-25-21	Resumed	Goldman	Neutral	$18
Oct-08-20	Initiated	Truist	Buy	$85
Apr-22-20	Initiated	Goldman	Buy	$60
Feb-27-20	Initiated	Barclays	Overweight	$64
Jun-10-19	Initiated	Robert W. Baird	Outperform	$24
Jun-10-19	Initiated	Cowen	Outperform
Jun-10-19	Initiated	Citigroup	Buy	$29

Show Previous Ratings

Jun-17-25 04:05PM	Applied Therapeutics Announces Key Leadership Appointments (GlobeNewswire) -6.81%
May-18-25 07:28AM	Applied Therapeutics Presents Full 12-Month Clinical Results and New Topline Data from INSPIRE Phase 2/3 Trial of Govorestat in CMT-SORD in Late-Breaking Oral Presentation at the Peripheral Nerve Society 2025 Annual Meeting (GlobeNewswire)
May-13-25 05:00PM	Applied Therapeutics Reports First Quarter 2025 Financial Results (GlobeNewswire) +10.25%
May-09-25 05:00PM	Applied Therapeutics Announces Acceptance of Late-Breaking Abstract for Oral Presentation at the Peripheral Nerve Society 2025 Annual Meeting (GlobeNewswire) +15.74%
May-07-25 08:10AM	Rhythm Pharmaceuticals, Inc. (RYTM) Reports Q1 Loss, Lags Revenue Estimates (Zacks)
05:50PM	Loading…
Apr-14-25 05:50PM	Applied Therapeutics Reports Fourth Quarter and Year-end 2024 Financial Results (GlobeNewswire) -11.06%
Apr-03-25 04:42PM	Russell 2000 Enters Bear Market With Small Caps Stung by Tariffs (Bloomberg) -7.01% +6.05%
Mar-31-25 07:10AM	Applied Therapeutics Files Form 12b-25 with the Securities and Exchange Commission (GlobeNewswire) -5.31%
Mar-19-25 07:00AM	Applied Therapeutics Appoints Todd F. Baumgartner, MD, MPH as Chief Regulatory Officer (GlobeNewswire)
Feb-28-25 05:54AM	Why pharma is still far from a treatment for galactosemia (Clinical Trials Arena)
Feb-04-25 05:45AM	Investors in Applied Therapeutics, Inc. Should Contact Levi & Korsinsky Before February 18, 2025 to Discuss Your Rights - APLT (PR Newswire)
Jan-21-25 07:00AM	Applied Therapeutics Appoints Reena Thomas Colacot as Vice President and Head of Quality (GlobeNewswire)
Jan-08-25 01:02PM	Investors in Applied Therapeutics, Inc. Should Contact Levi and Korsinsky Before February 18, 2025 to Discuss Your Rights APLT (GlobeNewswire) -9.54%
07:50AM	Is Applied Therapeutics (APLT) the Best Penny Stock to Invest In According to Media? (Insider Monkey)
Jan-06-25 09:13AM	Heres Why Applied Therapeutics, Inc. (NASDAQ:APLT) Is Among the Best Diabetes Stocks to Buy Under $10 (Insider Monkey) -7.36%
10:10AM	Loading…
Jan-02-25 10:10AM	Applied Therapeutics, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - APLT (PR Newswire)
Dec-29-24 01:13PM	APLT Purchasers Have Opportunity to Lead Applied Therapeutics, Inc. Securities Lawsuit (PR Newswire)
Dec-27-24 05:45AM	Applied Therapeutics, Inc. Sued for Securities Law Violations - Contact Levi and Korsinsky Before February 18, 2025 to Discuss Your Rights - APLT (PR Newswire)
Dec-24-24 03:31PM	APLT Purchasers Have Opportunity to Lead Applied Therapeutics, Inc. Securities Lawsuit (PR Newswire)
07:33AM	APPLIED FRAUD NOTICE: BFA Law Notifies Applied Therapeutics, Inc. Investors the Company was Sued for Fraud and Urges You to Contact the Firm (NASDAQ:APLT) (GlobeNewswire)
Dec-20-24 05:15PM	Penny Stock Applied Therapeutics' FDA Troubles Trigger Investor Lawsuit, Shareholders Claim Deception Over Govorestat Clinical Data (Benzinga) -13.72%
07:00AM	Applied Therapeutics Appoints John H. Johnson as Executive Chairman (GlobeNewswire)
Dec-18-24 08:29PM	APLT Purchasers Have Opportunity to Lead Applied Therapeutics, Inc. Securities Lawsuit (PR Newswire) -5.56%
Nov-30-24 06:40AM	Applied Therapeutics CRL a major setback, says William Blair (TipRanks)
05:30AM	Applied Therapeutics downgraded to Sector Perform from Outperform at RBC (TipRanks)
Nov-29-24 03:56PM	FDA Rejects Applied Therapeutics' NDA for Govorestat, Citing Flaws; Shares Plunge 76% (GuruFocus.com) -76.31%
10:49AM	Top Stock Movers Now: Hasbro, MicroStrategy, Super Micro Computer, and More (Investopedia)
10:48AM	Applied Therapeutics Stock Plummets 73%. The FDA Delivers This Crushing Blow. (Barrons.com)
10:06AM	Applied Therapeutics Stock Plummets After FDA Rejects Metabolic Disease Drug (Investopedia)
08:46AM	RBC downgrades Applied Therapeutics as FDA rejects Govorestat, hacks price target (Investing.com)
07:02AM	Loading…
Nov-28-24 07:02AM	Wait for galactosemia therapy goes on after FDA shuns Applied Therapeutics govorestat (Pharmaceutical Technology)
Nov-27-24 04:10PM	Applied Therapeutics Receives Complete Response Letter from U.S. FDA Regarding New Drug Application for Govorestat for Classic Galactosemia (GlobeNewswire) -16.06% -76.31%
Nov-07-24 07:00AM	Applied Therapeutics Reports Third Quarter 2024 Financial Results (GlobeNewswire)
Nov-05-24 07:00AM	Applied Therapeutics to Present at the 2024 UBS Global Healthcare Conference (GlobeNewswire)
Oct-29-24 12:00PM	Applied Therapeutics (APLT) Upgraded to Buy: Here's What You Should Know (Zacks)
09:40AM	Is Applied Therapeutics (APLT) Outperforming Other Medical Stocks This Year? (Zacks)
Oct-10-24 09:40AM	Are Medical Stocks Lagging Applied Therapeutics (APLT) This Year? (Zacks)
Sep-24-24 09:40AM	Is Applied Therapeutics (APLT) Stock Outpacing Its Medical Peers This Year? (Zacks) +5.53%
Sep-23-24 12:00PM	All You Need to Know About Applied Therapeutics (APLT) Rating Upgrade to Buy (Zacks)
Sep-18-24 10:56AM	Why Applied Therapeutics Stock Is Skyrocketing Today (Motley Fool) +68.82%
10:52AM	Applied Therapeutics Stock Soars As FDA Scraps Panel Meeting For Its Inherited Metabolic Disorder Drug (Benzinga)
07:00AM	Applied Therapeutics Provides Regulatory Update on Govorestat for the Treatment of Classic Galactosemia (GlobeNewswire)
Sep-04-24 07:00AM	Applied Therapeutics to Participate in Upcoming Investor Conferences (GlobeNewswire)
Aug-07-24 07:00AM	Applied Therapeutics Reports Second Quarter 2024 Financial Results (GlobeNewswire)
Jul-31-24 02:37PM	Rare Disease-Focused Applied Therapeutics' Lead Candidate Govorestat Has Blockbuster Potential, Analyst Sees 140% Stock Upside (Benzinga) +19.28%
Jul-01-24 07:00AM	Applied Therapeutics Added to Russell 3000 Index (GlobeNewswire)
Jun-29-24 08:50PM	Why Is Applied Therapeutics, Inc. (APLT) the Best Biotech Penny Stock to Buy Now? (Insider Monkey)
May-10-24 02:47PM	Applied Therapeutics Inc (APLT) Reports Q1 2024 Earnings: A Deep Dive into Financials and ... (GuruFocus.com)
May-09-24 01:55PM	APLT Stock Earnings: Applied Therapeutics Meets EPS, Misses Revenue for Q1 2024 (InvestorPlace)
07:00AM	Applied Therapeutics Reports First Quarter 2024 Financial Results (GlobeNewswire)
May-07-24 07:00AM	Applied Therapeutics to Present at the 2024 RBC Capital Markets Global Healthcare Conference (GlobeNewswire)
Apr-15-24 07:00AM	Applied Therapeutics Appoints Dale Hooks as Chief Commercial Officer (GlobeNewswire)
Apr-04-24 07:00AM	Applied Therapeutics to Present Results from Phase 3 ARISE-HF Study in Diabetic Cardiomyopathy at ACC 2024 (GlobeNewswire)
Mar-28-24 05:12PM	UPDATE 1-US FDA extends review of Applied Therapeutics' genetic disease drug (Reuters) -6.91%
04:42PM	US FDA extends review of Applied Therapeutics' genetic disease drug (Reuters)
04:30PM	Applied Therapeutics Provides FDA Update on PDUFA Target Action Date for Govorestat for the Treatment of Classic Galactosemia (GlobeNewswire)
Mar-13-24 09:23AM	Applied Therapeutics (APLT) Surges 124% in a Month: Here's Why (Zacks)
Mar-08-24 04:32AM	Applied Therapeutics Inc (APLT) Announces Year-End 2023 Financial Results and Clinical Progress (GuruFocus.com)
Mar-06-24 07:00AM	Applied Therapeutics Reports Fourth Quarter and Year-end 2023 Financial Results (GlobeNewswire)
Feb-28-24 01:01PM	FDA Grants Review Date For Applied Therapeutics' First Commercial Product For Rare Metabolic Disorder (Benzinga) +32.62%
09:48AM	Why Is Applied Therapeutics (APLT) Stock Up 59% Today? (InvestorPlace)
08:05AM	Applied Therapeutics Announces $100 Million Private Placement (GlobeNewswire)
08:00AM	Applied Therapeutics Announces FDA Acceptance and Priority Review of New Drug Application for Govorestat for the Treatment of Classic Galactosemia (GlobeNewswire)
Feb-21-24 09:21AM	13 Best Booming Stocks to Buy Right Now (Insider Monkey)
Feb-15-24 07:00AM	Applied Therapeutics Announces Positive Results from 12-month Interim Analysis of Govorestat (AT-007) in the Ongoing INSPIRE Phase 3 Trial in Sorbitol Dehydrogenase (SORD) Deficiency (GlobeNewswire) +39.93%
Jan-05-24 09:23AM	Why Is Applied Therapeutics (APLT) Stock Down 30% Today? (InvestorPlace) -40.63%
03:31AM	Constellation Brands, Costco, Peloton rise premarket; Apple, Tesla fall (Investing.com)
02:32AM	Applied Therapeutics fails heart disease phase 3, seeks partner to bring molecule to market (FierceBiotech.com)
Jan-04-24 04:05PM	Applied Therapeutics Announces Topline Results from the ARISE-HF Phase 3 Study of AT-001 in Diabetic Cardiomyopathy (GlobeNewswire) +5.57%
Jan-03-24 07:00AM	Applied Therapeutics Announces MAA Validation and NDA Submission of Govorestat (AT-007) for Treatment of Classic Galactosemia (GlobeNewswire)
Nov-09-23 08:34AM	Applied Therapeutics Inc (APLT) Reports Q3 2023 Financial Results Amidst Upcoming Clinical ... (GuruFocus.com) -10.39%
07:30AM	Applied Therapeutics Reports Third Quarter 2023 Financial Results (GlobeNewswire)
Nov-02-23 07:00AM	Applied Therapeutics to Present at the UBS Biopharma Conference 2023 (GlobeNewswire)
Nov-01-23 07:00AM	Applied Therapeutics to Host Diabetic Cardiomyopathy Expert Forum with Key Opinion Leaders on Tuesday, November 7 (GlobeNewswire)
Oct-20-23 01:22PM	12 Best Performing Biotech Stocks in 2023 (Insider Monkey)
Sep-28-23 07:00AM	Applied Therapeutics to Present Baseline Data from Phase 3 ARISE-HF Study Evaluating AT-001 at the 2023 EASD Annual Meeting (GlobeNewswire)
Sep-06-23 07:00AM	Applied Therapeutics Announces Successful Pre-NDA Meeting with the FDA and Confirms Plans to Submit NDA for Govorestat (AT-007) for Treatment of Classic Galactosemia to FDA in Q4 2023 (GlobeNewswire) +42.86%
Aug-11-23 07:42AM	We're A Little Worried About Applied Therapeutics' (NASDAQ:APLT) Cash Burn Rate (Simply Wall St.)
Aug-10-23 07:00AM	Applied Therapeutics Reports Second Quarter 2023 Financial Results (GlobeNewswire)
Jul-29-23 11:07AM	10 Stocks That Will Go Up 1000 Percent (Insider Monkey)
Jul-25-23 07:00AM	Applied Therapeutics Provides Regulatory Update on Galactosemia Program (GlobeNewswire) +6.38%
Jun-22-23 07:00AM	Applied Therapeutics to Present Baseline Data on the Phase 3 ARISE-HF Study in Diabetic Cardiomyopathy at the 2023 Annual Meeting of the American Diabetes Association (GlobeNewswire)
Jun-15-23 07:00AM	Applied Therapeutics to Present Data on AT-007 (Govorestat) Treatment in SORD Deficiency at the 2023 Annual Meeting of the Peripheral Nerve Society (GlobeNewswire)
May-25-23 07:00AM	Govorestat (AT-007) Receives Orphan Medicinal Product Designation from the EMA for Treatment of SORD Deficiency (GlobeNewswire)
May-11-23 07:00AM	Applied Therapeutics Reports First Quarter 2023 Financial Results (GlobeNewswire)
May-05-23 02:24PM	7 Hot Growth Stocks Poised to Triple in 2023 (InvestorPlace)
Apr-24-23 07:00AM	Applied Therapeutics, Inc. Announces $30 Million Private Placement of Equity (GlobeNewswire) +16.28%
07:00AM	Applied Therapeutics Announces Clinical Benefit of Govorestat (AT-007) in ACTION-Galactosemia Kids Trial; Company Plans to Meet with FDA Regarding Potential NDA Submission (GlobeNewswire)
Mar-23-23 06:30AM	Applied Therapeutics Reports Fourth Quarter and Year-end 2022 Financial Results (GlobeNewswire) -5.61%
Mar-18-23 09:54AM	Quite a few insiders invested in Applied Therapeutics, Inc. (NASDAQ:APLT) last year which is positive news for shareholders (Simply Wall St.)
Mar-01-23 07:00AM	Applied Therapeutics to Present at the Cowen 43rd Annual Health Care Conference (GlobeNewswire)
Feb-16-23 10:46AM	Applied Therapeutics Reveals Pivotal Study Data In Hereditary Neuropathy (Benzinga) +17.00%
07:00AM	Applied Therapeutics Announces Positive Sorbitol Reduction Data From the Ongoing Phase 3 INSPIRE Trial in Sorbitol Dehydrogenase (SORD) Deficiency (GlobeNewswire)
Feb-09-23 07:00AM	Applied Therapeutics to Present at the SVB Securities Global Biopharma Conference (GlobeNewswire)
Jan-04-23 06:00AM	Applied Therapeutics Announces Partnership with Advanz Pharma for Commercialization of AT-007 (Govorestat) in Europe (GlobeNewswire) +15.28%
Nov-09-22 07:00AM	Applied Therapeutics Reports Third Quarter 2022 Financial Results (GlobeNewswire) -8.62%
Oct-31-22 07:00AM	Applied Therapeutics Announces Multiple Data Presentations at the American Heart Association Scientific Sessions November 5-7, 2022 (GlobeNewswire) +6.73%
Oct-25-22 07:00AM	Applied Therapeutics Announces Full Enrollment in the Registrational Phase 3 ARISE-HF Trial of AT-001 in Diabetic Cardiomyopathy (GlobeNewswire) +6.91%
Oct-09-22 09:13AM	Insiders who purchased Applied Therapeutics, Inc. (NASDAQ:APLT) earlier this year lose an additional US$86k as the stock sinks to US$0.62 (Simply Wall St.)
Oct-06-22 11:18AM	Applied Therapeutics' Lead Candidate Pediatric Study Failed To Reach Statistical Significance (Benzinga) -33.47%

Applied Therapeutics, Inc. is a clinical-stage biopharmaceutical company which engages in the development of a pipeline of novel products. It is targeting treatments for central nervous system rare diseases and diabetic complications. The company was founded by Shoshana Shendelman on January 20, 2016 and is headquartered in New York, NY.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Perfetti Riccardo	Chief Medical Officer	Mar 04 '25	Sale	0.44	10,366	4,561	890,409	Mar 06 08:30 PM
Funtleyder Leslie D.	See Remarks	Mar 04 '25	Sale	0.44	14,502	6,381	390,459	Mar 06 08:30 PM
Chinoporos Constantine	See Remarks	Mar 04 '25	Sale	0.44	447	197	271,436	Mar 06 08:30 PM
Funtleyder Leslie D.	See Remarks	Feb 06 '25	Sale	0.61	22,950	14,000	404,961	Feb 07 08:30 PM
Perfetti Riccardo	Chief Medical Officer	Feb 06 '25	Sale	0.61	86,078	52,508	900,775	Feb 07 08:30 PM
Chinoporos Constantine	See Remarks	Feb 06 '25	Sale	0.61	28,117	17,151	271,883	Feb 07 08:30 PM
Funtleyder Leslie D.	Chief Financial Officer	Aug 22 '24	Sale	5.83	13,530	78,880	277,911	Aug 23 04:35 PM
Perfetti Riccardo	Chief Medical Officer	Aug 22 '24	Sale	5.83	22,681	132,230	986,853	Aug 23 04:33 PM
Shendelman Shoshana	President and CEO	Aug 13 '24	Sale	6.18	357,423	2,208,874	4,810,430	Aug 14 07:01 PM
Shendelman Shoshana	President and CEO	Aug 12 '24	Sale	5.98	300,000	1,794,000	5,167,853	Aug 14 07:01 PM
Shendelman Shoshana	President and CEO	Aug 14 '24	Sale	5.93	119,591	709,175	4,690,839	Aug 14 07:01 PM
Shendelman Shoshana	Officer	Aug 12 '24	Proposed Sale	6.21	1,000,000	6,210,000		Aug 09 08:43 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

APLT

Applied Therapeutics Inc

Upgrade your FINVIZ experience